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Parasitology as a subject has a long history in Africa both
in the medical and veterinary fields ranging from the iden-
tification of parasites to the development of interventions.
For example, both of the parasites of major public health
concern in tropical countries were discovered in Africa
despite occurring in other parts of the world. Thus, the
Plasmodium parasite causing malaria was discovered by
Charles Louis Alphonse Laveran, a French army surgeon
stationed in Constantine, Algeria, on the 6th of November
1880, a discovery for which he was awarded the Nobel Prize
in 1907. The livestock protozoan Theileria parva, which
causes East Coast Fever in cattle, was also discovered in Africa
by Arnold Theiler and Charles Lounsbury in South Africa in
1904. In 1851, Theodor Bilharz, discovered the blood fluke
parasite (Schistosoma haematobium) which causes bilharzia
or snail fever, during a postmortem examination at the Kasr-
el-Aini hospital in Cairo.
Since these discoveries, there have been concerted eﬀorts
worldwide to find interventions ranging from drugs used
to kill parasites in human hosts (quinine; artemisinins for
Plasmodium and the antihelminthics metrifonate; oxam-
niquine and praziquantel for schistosomes), drugs to kill
vectors/intermediate hosts (dichlorodiphenyltrichloroethane
(DDT) for Plasmodium mosquito vectors; acaricides for tick
vectors of Theileria and copper sulphate/niclosamide for
killing schistosome snail hosts), and barriers to prevent the
contact of human hosts and infective stages (e.g., bed nets
for Plasmodium).
With the description of life cycles of not only these para-
sites but other protozoans (e.g., Giardia) and helminths (e.g.,
hookworms), the importance of sanitation, hygiene and
clean water became apparent, and these lead to inventions
such as the Blair toilet, a simple pit latrine developed in
Zimbabwe and safe drinking water wells. These develop-
ments hold true to the observation by the Roman Scholar
and Scientist Pliny the Elder (23 AD–79 AD) that “there is
always something new out of Africa,” albeit it is in a diﬀerent
context.
With technological advances in this postgenomic era,
collaborations between scientists in diﬀerent institutions
and countries in Africa as well as collaborations between
African scientists and those in other continents (loosely
termed north-south collaborations) have allowed scientists
to conduct cutting-edge target-species-oriented research.
The development and fostering of these collaborations and
partnerships themselves have been as vital as the technolog-
ical advances in eﬀorts to control parasitic diseases. Thus,
for example, work on RTS,S, the world’s most clinically
advanced malaria vaccine candidate [1], has included 11
clinical trial sites in seven African countries: Burkina Faso,
Gabon, Ghana, Kenya, Malawi, Mozambique, and Tanzania
with over 15,000 participants, and industrial (GlaxoSmithK-
line), research (PATH Malaria Vaccine Initiative), and NGO
(Bill & Melinda Gates Foundation) partners involved in
over 20 years of work. Independent of the outcome of the
clinical trials, this level of collaboration sets a precedent
for all future programmes for better interventions for
parasitic diseases in Africa. The basic scientific work for such
collaborative studies is already currently being conducted in
Africa as exemplified by work published in this special issue.
These include detection of parasites in wildlife as reported
by Munang’andu et al. Parasite surveillance of wildlife is
important not only for monitoring parasites that aﬀect
domestic animals but also for identifying emerging zoonotic
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parasites and pathogens. Once parasites are identified on
hosts, there is need for reliable diagnostic methods which are
applicable in clinical and field settings as appropriate. Clive
Shiﬀ sets out the case for the need for definitive diagnosis for
urogenital schistosomiasis and the pathology arising during
chronic infection. The diagnostic method focused on by Shiﬀ
relies on recent advances in molecular biology, polymerase
chains reaction (PCR), which detects parasite fragments in
urine. Wumba et al. also use PCR to detect the presence
of Enterocytozoon bieneusi, a microsporidia parasite that has
become an important opportunistic infection aﬀecting AIDS
patients [2]. Opportunistic parasites/pathogens represent
one of the clearest demonstrations of coinfections that
occur in human and animal populations. The eﬀect of
one infection on the immune system can influence the
susceptibility of a host to infection by a second pathogen (as
occurs in the case of HIV immune-compromised individu-
als), disease progression (HIV progression during helminth
infection [3]), and pathological processes (liver pathology
in children infected with malaria parasites and schistosomes
[4]). Perhaps counterintuitively, some infections can protect
against infection by others, for example, the helminth Ascaris
lumbricoides can protect against Plasmodium falciparum
infection [5] or against pathology from another parasite
(e.g., intestinal helminthes can protect against anemia during
an acute malarial attack by P. vivax [6]). These examples
show that these associations are both complex and context-
dependent. One of the reasons for such complexity is
heterogeneity in various host attributes such as genetic
background and nutritional status. The study by Reilly et al.
focuses on micronutrients which play an important role in
the development and function of the immune system. This
study highlights the association between micronutrients and
cytokines (mediators of immune responses) in schistosome-
infected people.
As mentioned earlier, environmental factors such as
water sources and toilets aﬀect transmission of several
parasites. This means that successful control strategies must
address the contribution of these factors. In his article on
schistosome control strategies, Moses Chimbari highlights
the importance of an integrated and multisectorial approach
for successful parasite control using examples from Zim-
babwe. Gosh et al. extend this concept by highlighting the
importance of socioeconomic, political, and cultural aspects
in successful control of parasitic diseases.
All the studies published in this special issue illustrate
the importance of multidisciplinary approaches in basic
research to develop eﬀective interventions as well as an
understanding of the interactions between environmental,
socioeconomic, political, and cultural influences on trans-
mission and delivery of the interventions for successful
and sustainable control. For several parasites, these issues
are already known and well understood, and there are
already eﬃcacious control methods available, the immediate
challenge is to make eﬀective use of this knowledge and the
tools currently available. The future challenge is to keep ahead
of the parasites by eﬀective surveillance for (1) emerging
parasites and (2) changes in the parasite phenotypes and
their frequencies in response to control eﬀorts and then
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